{"id":"NCT01888497","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers","officialTitle":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, CROSS-OVER, PLACEBO-CONTROLLED, SINGLE DOSE, CLINICAL TRIAL TO ASSESS THE NEXT-DAY RESIDUAL EFFECTS OF GABAPENTIN, DIPHENHYDRAMINE AND TRIAZOLAM ON SIMULATED DRIVING PERFORMANCE IN NORMAL VOLUNTEERS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-29","primaryCompletion":"2013-12-14","completion":"2013-12-14","firstPosted":"2013-06-27","resultsPosted":"2021-02-05","lastUpdate":"2021-02-21"},"enrollment":59,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Healthy"],"interventions":[{"type":"DRUG","name":"Gabapentin","otherNames":[]},{"type":"DRUG","name":"Diphenhydramine citrate","otherNames":[]},{"type":"DRUG","name":"Triazolam","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Arm A","type":"EXPERIMENTAL"},{"label":"Arm B","type":"EXPERIMENTAL"},{"label":"Arm C","type":"ACTIVE_COMPARATOR"},{"label":"Arm D","type":"PLACEBO_COMPARATOR"}],"summary":"This study will examine the next-day residual effects of a nighttime dose of gabapentin 250 mg, diphenhydramine citrate 76 mg and triazolam 0.5 mg compared to placebo and each other on simulated driving performance in normal volunteer subjects. It will also examine other measures of next-day performance and next-day sleepiness.","primaryOutcome":{"measure":"Standard Deviation of Lateral Position (SDLP)","timeFrame":"7.25 hours post-dose","effectByArm":[{"arm":"Placebo","deltaMin":33.2,"sd":8},{"arm":"Gabapentin","deltaMin":34.2,"sd":10},{"arm":"Diphenhydramine Citrate","deltaMin":35.4,"sd":8.9},{"arm":"Triazolam","deltaMin":47.4,"sd":12}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG001","p":null},{"comp":"OG001 vs OG002","p":"0.134"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"25 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A9451178&StudyName=Next-Day%20Residual%20Effects%20of%20Gabapentin%2C%20Diphenhydramine%20and%20Triazolam%20on%20Simulated%20Driving%20Performance%20in%20Normal%20Volunteers"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":58},"commonTop":["Somnolence","Nausea","Lethargy","Headache","Vision blurred"]}}